Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and molecular pathways without original human data
PubMed 31361624 · doi:10.1097/MOL.0000000000000626
What was done
This narrative review summarizes recent discoveries regarding the mechanisms of intestinal lipid transport via lymphatic vessels (lacteals), focusing on regulatory signaling pathways and potential therapeutic targets for metabolic disorders.
What was found
The review outlines that chylomicron entry into lacteals and subsequent lymph transport operate through active regulation involving the autonomic nervous system, transcription factors (such as PLAGL2), and signaling regulators including VEGF-A/Nrp1/VEGFR1, VEGF-C/VEGFR3, DLL4, CALCRL, and GLP-2. No quantitative metrics or effect sizes were reported in the abstract.
Why it matters
Understanding the active molecular regulation of intestinal lacteals highlights novel therapeutic strategies for treating dyslipidemia, obesity, atherosclerosis, and fatty liver disease, and supports targeted lymphatic drug delivery.
Limits
The abstract describes a non-systematic narrative review providing no primary clinical data, quantitative findings, or study sample sizes. Mechanisms discussed rely primarily on preclinical models, and clinical translatability remains to be evaluated.
Cited by
- supports Dietary fat is absorbed through the lymphatic system rather than directly into the bloodstream.